Loughborough University
Leicestershire, UK
LE11 3TU
+44 (0)1509 263171
Loughborough University

Loughborough University Institutional Repository

Please use this identifier to cite or link to this item: https://dspace.lboro.ac.uk/2134/28455

Title: Novel interventions for recalcitrant Achilles Tendinopathy: Benefits seen following high- volume image-guided injection or extracorporeal shockwave therapy—A prospective cohort study
Authors: Wheeler, Patrick C.
Tattersall, Chloe
Keywords: Achilles tendon
High-energy shock waves
Injection
Patient-reported outcome
Issue Date: 2018
Publisher: Lippincott, Williams & Wilkins
Citation: WHEELER, P.C. and TATTERSALL, C., 2018. Novel interventions for recalcitrant Achilles Tendinopathy: Benefits seen following high- volume image-guided injection or extracorporeal shockwave therapy—A prospective cohort study. Clinical Journal of Sport Medicine, In Press.
Abstract: Objective: To compare the outcomes for patients with chronic noninsertional Achilles tendinopathy following extracorporeal shockwave therapy (ESWT) and high-volume image-guided injection (HVIGI). Design: Prospective cohort study. Setting: Hospital-based Sports Medicine Outpatient Clinic. Patients: Sixty-three consecutive patients with chronic noninsertional Achilles tendinopathy, treated with ESWT (n522) or HVIGI (n541), with minimum 3-month follow-up. Mean age was 51.2 years, and mean duration of symptoms was 27.8 months. Interventions: Patients received either 3 sessions of ESWT (1 session per week) or a single ultrasound-guided HVIGI (10 mL of 1% lidocaine and 40 mLs of sterile saline). All patients received standardized aftercare, including continuation of a structured home exercise program of flexibility and eccentric strengthening exercises. MainOutcome Measures: Zero to 10 visual analog scale (VAS) for self-reported “average pain” and “average stiffness” values. In addition, Victoria Institute of Sport—Achilles questionnaire, (VISA-A), and Manchester-Oxford Foot Questionnaire (MOXFQ). Results: This study demonstrated statistically significant improvements in self-reported measures of pain and stiffness following either procedure. At 3 months, VAS (pain) was improved from 6.7461.31 to 3.5762.37 (P,0.001) following HVIGI and from 6.5761.61 to 4.356 AU3 2.55 (P50.002) following ESWT. At 3months, VISA-A improved from35%617%to 51%622%(P,0.001) following HVIGI and from 34%615% to 49%615% (P,0.001) following ESWT. Statistically significant improvements were only recorded at 6 weeks for ESWT and at 3 months for HVIGI using MOXFQ. No statistically significant differences were seen between the groups at any period studied. Conclusions: Patients improved to statistically significant extent following either a HVIGI or ESWT procedure, with no significant differences seen between the groups. The small sample sizes in this pragmatic study are noted, which limit interpretation, and larger more robust studies are required to investigate this further. Clinical Relevance: This pragmatic prospective cohort study demonstrates improvements following either ESWT or HVIGI procedures, with no significant differences seen between the groups.
Description: This paper is in closed access.
Version: Published version
DOI: 10.1097/JSM.0000000000000580
URI: https://dspace.lboro.ac.uk/2134/28455
Publisher Link: https://doi.org/10.1097/JSM.0000000000000580
ISSN: 1536-3724
Appears in Collections:Closed Access (Sport, Exercise and Health Sciences)

Files associated with this item:

File Description SizeFormat
CJSM-17-429 - author.pdfPublished version289.91 kBAdobe PDFView/Open

 

SFX Query

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.